Benzinga··Mohd HaiderImpact Biomedical Stock Soars 86% on Merger Extension, Share Restructuring
Impact Biomedical shares surge 86% after SEC filing extends merger with Dr Ashley's Bio Labs to July 2026 and restructures equity allocation.
IBODSSmergerSEC filing